Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Rituximab Related Flare by Plasmapheresis in Cryoglobulinemic Vascularitis

NCT04692363 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04692363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04692363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Rituximab Related Flare by Plasmapheresis in Cryoglobulinemic Vascularitis
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Unknown status
Start date
January 1, 1999
Completion date
December 31, 2021
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryoglobulinemic vasculitis